$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Where can I buy crizotinib 60 tablets?
2025-10-19 11:44:20
Check Details
What to do after osimertinib is resistant to lung cancer treatment?
2025-10-19 11:44:20
Check Details
What are the functions and efficacy of sotoraxibu (AMG510)?
2025-10-19 11:44:20
Check Details
What are the effects and side effects of erlotinib?
2025-10-19 11:44:20
Check Details
Will Erlotinib be launched in 2024?
2025-10-19 11:44:20
Check Details
When will sotoraxibu be available in China? _ Kanghule
2025-10-19 11:44:20
Check Details
Efficacy and effects of Mobocertinib
2025-10-19 11:44:20
Check Details
What are the precautions and contraindications of the new lung cancer drug Platinib?
2025-10-19 11:44:20
Check Details
Where can I buy the new lung cancer drug Platinib? _ Kanghule
2025-10-19 11:44:20
Check Details
Can genuine Mobotinib be purchased in the country? _ Kanghule
2025-10-19 11:44:20
Check Details
Where can I buy genuine larotrectinib in China?
2025-10-19 11:44:20
Check Details
How long will it take for the side effects of Capmatinib to appear? _ Kanghule
2025-10-19 11:44:20
Check Details
1
2
...
4132
4133
4134
4135
4136
4137
4138
...
4154
4155
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Garsorasib Clinical Updates and KRAS G12C Targeted Therapy Prospects
2
FDA Accelerates Approval of Zongertinib: Precision Medicine Advancement for HER2-Mutated NSCLC
3
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
4
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
5
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
6
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
7
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
8
Adagrasib Medication Management Guide for Special Populations
9
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
10
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
11
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
12
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer